Back to Search
Start Over
Low seropositivity for SARS-CoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece
- Source :
- Public Health
- Publication Year :
- 2021
- Publisher :
- The Royal Society for Public Health. Published by Elsevier Ltd., 2021.
-
Abstract
- Objectives To estimate the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity among healthcare workers (HCWs) in Greece and to identify high-risk groups in healthcare facilities. Study design The study design used in this study is a nationwide cross-sectional study. Methods Data were collected from 1 June to 9 July 2020. HCWs in the Greek National Health System were offered a free SARS-CoV-2 IgG antibody test, regardless of symptoms. Results Overall, 379 of 57,418 HCWs (0.66%, 95% confidence interval [CI]: 0.59–0.73) were positive for SARS-CoV-2 antibodies. The adjusted overall seroprevalence was 0.43% (95% CI: 0.35–0.51). We found that HCWs in non-reference hospitals for COVID-19 (odds ratio [OR]: 1.81, 95% CI: 1.23–2.64; P = 0.002) and reference hospitals for COVID-19 (OR: 1.66, 95% CI: 1.06–2.58; P = 0.03) were more likely to be seropositive than HCWs in primary care centres. Regarding professions, nurses (OR: 1.45, 95% CI: 1.07–1.98; P = 0.02), physicians (OR: 1.43, 95% CI: 1.06–1.93; P = 0.02), and administrative, cleaning and security staff (OR: 1.50, 95% CI: 1.09–2.06; P = 0.01) had a statistically higher chance of having a positive serology than laboratory employees. Conclusions The adjusted overall seroprevalence found in this study indicates a very low prevalence of SARS-CoV-2 among HCWs in Greece. This result is in line with the low incidence of COVID-19 during the first wave of the pandemic and is a direct benefit from the early implementation of lockdown.
- Subjects :
- medicine.medical_specialty
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Health Personnel
Seroepidemiologic Studies
Internal medicine
Pandemic
Health care
Medicine
Seroprevalence
Humans
antibodies
Pandemics
Original Research
biology
seroprevalence
Greece
business.industry
SARS-CoV-2
healthcare workers
Incidence (epidemiology)
Public Health, Environmental and Occupational Health
COVID-19
General Medicine
Odds ratio
Confidence interval
Cross-Sectional Studies
Communicable Disease Control
biology.protein
Antibody
business
Subjects
Details
- Language :
- English
- ISSN :
- 14765616 and 00333506
- Database :
- OpenAIRE
- Journal :
- Public Health
- Accession number :
- edsair.doi.dedup.....ed5e9ec90bf57b52d70a4bd6c78ad728